Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2019 Oct;104(10):e483-e486.
doi: 10.3324/haematol.2018.208397. Epub 2019 May 9.

Immunodeficiency, autoimmune thrombocytopenia and enterocolitis caused by autosomal recessive deficiency of PIK3CD-encoded phosphoinositide 3-kinase δ

Affiliations
Case Reports

Immunodeficiency, autoimmune thrombocytopenia and enterocolitis caused by autosomal recessive deficiency of PIK3CD-encoded phosphoinositide 3-kinase δ

David J Swan et al. Haematologica. 2019 Oct.
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
PIK3CD mutation in a patient with immunodeficiency and immune dysregulation. (A) Pedigree. (B) Hematoxylin & eosin staining showing colitis and crypt abscess formation. (C) Immunostaining for CD3 (gold) and CD20 (purple); P1, patient; HD, healthy donor. (D) CCR7 and CD45RA staining and quantification of memory CD8+ cells among CD25CD8+ cells. (E) Expression of perforin and transcription factor TBET in naïve and memory CD8+ T cells. (F) Sanger sequencing confirming frameshift deletion plus 2bp insertion. (G) p110δ schematic showing p.Q170Vfs*41 and previously reported mutations.
Figure 2.
Figure 2.
Functional impact of PIK3CD mutation. (A) Immunoblotting of p110δ, AKT, pAKTT308, pERKT202/Y204, pS6S235/236 and beta-actin in control (HD) and patient (P1) CD4+ and CD8+ T lymphoblasts with and without CD3 stimulation. (B) PIP3 quantification before/after T-cell receptor (TCR) stimulation. (C) and (D) Extracellular acidification rate (Seahorse assay) and quantification of glycolysis in IL-2-stimulated T lymphoblasts of HD and P1 (C) or HD cells treated with idelalisib (D). Three independent experiments with 5-8 technical replicates each; values are plotted as mean of three time points for each injection and each replicate (**P<0.01 and ***P<0.001, Mann-Whitney U test).

Similar articles

Cited by

References

    1. Lucas CL, Chandra A, Nejentsev S, Condliffe AM, Okkenhaug K. PI3Kδ and primary immunodeficiencies. Nat Rev Immunol. 2016;16(11):702–714. - PMC - PubMed
    1. Coulter TI, Chandra A, Bacon CM, et al. Clinical spectrum and features of activated phosphoinositide 3-kinase δ syndrome: A large patient cohort study. J Allergy Clin Immunol. 2017;139(2):597-606. - PMC - PubMed
    1. Okkenhaug K, Bilancio A, Farjot G, et al. Impaired B and T cell antigen receptor signalling in p110δ PI 3-kinase mutant mice. Science. 2002;297(5583):1031–1034. - PubMed
    1. Patton DT, Garden OA, Pearce WP, et al. Cutting edge: the phosphoinositide 3-Kinase p110 is critical for the function of CD4+CD25+Foxp3+ regulatory T cells. J Immunol. 2006; 177(10):6598–6602. - PubMed
    1. Stark AK, Sriskantharajah S, Hessel EM, Okkenhaug K. PI3K inhibitors in inflammation, autoimmunity and cancer. Curr Opin Pharmacol. 2015;23:82–91. - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources